Back to Screener

Heartbeam, Inc. Warrant (BEATW)

Price$0.10

Favorite Metrics

Price vs S&P 500 (26W)-79.36%
Price vs S&P 500 (4W)-21.77%

All Metrics

Price vs S&P 500 (YTD)-69.56%
10-Day Avg Trading Volume0.00M
3-Month Avg Trading Volume0.02M
52-Week High$0.78
26-Week Price Return-70.61%
13-Week Price Return-53.78%
3-Month Return Std Dev220.95%
Year-to-Date Return-66.94%
5-Day Price Return-11.91%
Month-to-Date Return-11.91%
Price vs S&P 500 (13W)-56.64%
Beta0.58x
52-Week Low$0.07

Industry Peers — Surgical & Medical Instruments(109)

SymbolP/S Ratio (TTM)Revenue Growth (5Y)Gross Margin (TTM)Operating Margin (TTM)Price
BEATWHeartbeam, Inc. Warrant
$0.10
SYKStryker Corporation
5.17x11.84%64.57%19.43%$338.34
BSXBoston Scientific Corp.
4.58x15.16%69.01%18.00%$60.99
MMM3M Company
3.21x-4.97%39.92%18.55%$151.40
MDLNMedline Inc. Class A common stock
2.20x26.44%7.78%$48.26
BDXBecton, Dickinson and Co.
2.06x6.32%46.42%12.15%$158.64
RMDResMed Inc.
6.07x11.72%60.85%33.70%$226.14
DXCMDexCom, Inc.
5.33x19.33%62.09%19.56%$64.62
WSTWest Pharmaceutical Services, Inc.
6.29x7.44%35.91%19.03%$278.00
PODDInsulet Corporation
5.19x24.53%71.63%12.92%$200.87
PENPenumbra, Inc.
9.24x20.16%67.14%13.48%$329.71

About

HeartBeam develops higher-resolution ambulatory ECG devices designed to detect and monitor cardiac disease outside traditional healthcare facilities using its proprietary Vector Electrocardiography platform. The company's telehealth-enabled solutions address the growing market for remote cardiac monitoring. HeartBeam is advancing toward FDA clearance for its initial products.